Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii. - Wikidata - wikimedia - TriplyDB

Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.

Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.

http://www.wikidata.org/entity/Q34058104

about

Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin Novel strategies against Candida biofilms: interest of synthetic compounds.Evaluation of the antileishmanial potency, toxicity and phytochemical constituents of methanol bark extract of Sterculia villosa.The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.Growth Inhibition and Membrane Permeabilization of Candida lusitaniae Using Varied Pulse Shape Electroporation.What Could Be the Role of Antifungal Lock-Solutions? From Bench to Bedside.

P2860

Q37246227-C0CC4DE8-4182-4414-96CA-52AC25E5EAD9 Q38670904-B61AE263-A8A4-4E93-A0A5-6D373223C676 Q40341436-540C439E-0D43-4267-8679-C51686AAFE86 Q40910138-B66CBD69-5E69-484E-A0BA-83BB1BB39E6E Q42178504-044F2EA4-04C9-4446-824F-E9F6A3ED7851 Q48544823-3AD3FBF8-F891-472B-8F03-D0A5585B3B96

P2860

Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.

http://www.wikidata.org/entity/Q34058104

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@ast

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@en

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@nl

type

label

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@ast

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@en

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@nl

prefLabel

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@ast

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@en

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@nl

P1433

Q34058104-27CDD753-EB96-46B5-B2DC-D0FC5AF31F23

P1476

Q34058104-87673CC6-3D37-4A8D-9E77-869690885DC4

P2093

Q34058104-02417B85-E31A-4FEE-B8E7-4C94D27FAC0D

Q34058104-4D334FAC-11AE-486A-8737-62E81D2B57B8

Q34058104-7DF8476A-6FCD-4524-B291-7496994FFC16

Q34058104-93CFE8FA-725D-46C4-A9E8-A672568A7DAD

P2860

Q34058104-00B9A7AE-3440-4644-9832-47F417C99121

Q34058104-0777661C-D694-4DD6-B380-66CAE9DF90E5

Q34058104-10198AD8-6FFC-4500-BA03-4CB7BBF3AC90

Q34058104-13CA92B5-8DC6-4C82-8EB6-3F791053D8C6

Q34058104-24DC6974-6D7C-4905-9BB5-6E115317F089

Q34058104-38E974FC-821B-40C1-808D-67F7BB0CAA89

Q34058104-4C05595B-A772-4E63-B6C3-0A07035B5C8D

Q34058104-569065DC-0ABF-475F-BFF1-851B7FC00658

Q34058104-6225B94E-2721-4005-8A5F-6BEB8FB2358B

Q34058104-65B3C3B9-610B-4FB2-AABA-3AE26A107B71

P304

Q34058104-B6B2B3F2-E385-4C25-A3E8-7760335F07BB

P31

Q34058104-DBF1CBF4-D6B7-4FA1-9197-64AE69BF702E

P356

Q34058104-193B6ECD-966A-4024-98E5-2F4120D36EBE

P407

Q34058104-3400803F-3724-4816-9F95-55F21E077681

P433

Q34058104-64B6545C-6085-4F1A-91FC-88FFD642EAAE

P478

Q34058104-A6B92078-725B-4975-A5A7-BB130CBF08AD

P50

Q34058104-CF89A05B-96E2-45B2-94A0-04BEF516A7FC

P577

Q34058104-3E44E4C1-825C-4DD9-B681-4DEC99923208

P5875

Q34058104-04BCDA69-05AD-478B-9DBA-AAF9791D60F7

P698

Q34058104-6EAF359C-D2E3-41CC-8485-AE633050F2BE

P921

Q34058104-488529B6-D409-4BB5-B556-F1049C6A1C30

Q34058104-7A013B21-9F03-4516-B5B6-3EEA0CFC8E45

P932

Q34058104-4CD4B727-2F2F-4135-B405-0838F502CC93

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Caspofungin at catheter lock c ...... ae and Candida guilliermondii.

@en

P2093

Aristea Velegraki

http://www.w3.org/2001/XMLSchema#string

Daniela Kyrpitzi

http://www.w3.org/2001/XMLSchema#string

Maria Simitsopoulou

http://www.w3.org/2001/XMLSchema#string

Thomas J Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Antifungal lock therapy

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.

Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.

Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Clinical outcomes of dialysis catheter-related candidemia in hemodialysis patients.

A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.

Occurrence, presentation and treatment of candidemia.

P304

4953-4956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.03117-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuel Roilides

P577

2014-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262813290

http://www.w3.org/2001/XMLSchema#string

P698

24890585

http://www.w3.org/2001/XMLSchema#string

P921

catheterization

P932

4136003

http://www.w3.org/2001/XMLSchema#string